What is Thrombolex worth?
$96.0Mlast known valuation
Thrombolex last raised $9.8M in its Debt (Apr 2017).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Thrombolex
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2017 | Debt | $9.8M | ▮ | ▮ |
How Thrombolex's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Thrombolex, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Thrombolex worth?
- Thrombolex's last known valuation is $96.0M.
- How much has Thrombolex raised?
- Thrombolex has raised $75.6M in total funding across 1 recorded rounds.
- When did Thrombolex last raise?
- Thrombolex last raised in Apr 2017 (Debt), raising $9.8M.